Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 293

Similar articles for PubMed (Select 20808922)

1.

Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction.

Wan YW, Sabbagh E, Raese R, Qian Y, Luo D, Denvir J, Vallyathan V, Castranova V, Guo NL.

PLoS One. 2010 Aug 17;5(8):e12222. doi: 10.1371/journal.pone.0012222.

2.

Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.

Wan YW, Beer DG, Guo NL.

Lung Cancer. 2012 Apr;76(1):98-105. doi: 10.1016/j.lungcan.2011.09.016. Epub 2011 Nov 1.

3.

Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.

Guo NL, Wan YW.

Artif Intell Med. 2012 Jun;55(2):97-105. doi: 10.1016/j.artmed.2012.01.001. Epub 2012 Feb 11.

4.

Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity.

Hsu YC, Chen HY, Yuan S, Yu SL, Lin CH, Wu G, Yang PC, Li KC.

BMC Med. 2013 Apr 16;11:106. doi: 10.1186/1741-7015-11-106.

5.

Gene expression signature predicts recurrence in lung adenocarcinoma.

Larsen JE, Pavey SJ, Passmore LH, Bowman RV, Hayward NK, Fong KM.

Clin Cancer Res. 2007 May 15;13(10):2946-54.

6.

Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.

Lu Y, Wang L, Liu P, Yang P, You M.

PLoS One. 2012;7(1):e30880. doi: 10.1371/journal.pone.0030880. Epub 2012 Jan 23.

7.

Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.

Guo NL, Wan YW, Tosun K, Lin H, Msiska Z, Flynn DC, Remick SC, Vallyathan V, Dowlati A, Shi X, Castranova V, Beer DG, Qian Y.

Clin Cancer Res. 2008 Dec 15;14(24):8213-20. doi: 10.1158/1078-0432.CCR-08-0095.

8.

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, Pintilie M, Der S, Seymour L, Jurisica I, Shepherd FA, Tsao MS.

J Clin Oncol. 2010 Oct 10;28(29):4417-24. doi: 10.1200/JCO.2009.26.4325. Epub 2010 Sep 7. Erratum in: J Clin Oncol. 2010 Dec 1;28(34):5126. J Clin Oncol. 2014 Feb 1;32(4):365.

9.

Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.

Raponi M, Zhang Y, Yu J, Chen G, Lee G, Taylor JM, Macdonald J, Thomas D, Moskaluk C, Wang Y, Beer DG.

Cancer Res. 2006 Aug 1;66(15):7466-72.

10.
11.

A population-based gene signature is predictive of breast cancer survival and chemoresponse.

Rathnagiriswaran S, Wan YW, Abraham J, Castranova V, Qian Y, Guo NL.

Int J Oncol. 2010 Mar;36(3):607-16.

12.

Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma.

Yamauchi M, Yamaguchi R, Nakata A, Kohno T, Nagasaki M, Shimamura T, Imoto S, Saito A, Ueno K, Hatanaka Y, Yoshida R, Higuchi T, Nomura M, Beer DG, Yokota J, Miyano S, Gotoh N.

PLoS One. 2012;7(9):e43923. doi: 10.1371/journal.pone.0043923. Epub 2012 Sep 19.

13.

Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.

Guo L, Ma Y, Ward R, Castranova V, Shi X, Qian Y.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3344-54.

14.

Expression profiling defines a recurrence signature in lung squamous cell carcinoma.

Larsen JE, Pavey SJ, Passmore LH, Bowman R, Clarke BE, Hayward NK, Fong KM.

Carcinogenesis. 2007 Mar;28(3):760-6. Epub 2006 Nov 1.

15.

Gene expression-based classification of non-small cell lung carcinomas and survival prediction.

Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens JA, Hoogsteden HC, Grosveld F, Philipsen S.

PLoS One. 2010 Apr 22;5(4):e10312. doi: 10.1371/journal.pone.0010312.

16.

Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients.

Der SD, Sykes J, Pintilie M, Zhu CQ, Strumpf D, Liu N, Jurisica I, Shepherd FA, Tsao MS.

J Thorac Oncol. 2014 Jan;9(1):59-64. doi: 10.1097/JTO.0000000000000042.

PMID:
24305008
17.

A simple two-gene prognostic model for adenocarcinoma of the lung.

Reed CE, Graham A, Hoda RS, Khoor A, Garrett-Mayer E, Wallace MB, Mitas M.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):627-34. doi: 10.1016/j.jtcvs.2007.10.058. Epub 2008 Jan 18.

18.

A prognostic test for adenocarcinoma of the lung from gene expression profiling data.

Gordon GJ, Richards WG, Sugarbaker DJ, Jaklitsch MT, Bueno R.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):905-10.

19.

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, Govindan R, You M.

PLoS Med. 2006 Dec;3(12):e467.

20.

A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.

Toh SH, Prathipati P, Motakis E, Kwoh CK, Yenamandra SP, Kuznetsov VA.

BMC Genomics. 2011 Nov 30;12 Suppl 3:S24. doi: 10.1186/1471-2164-12-S3-S24. Epub 2011 Nov 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk